Fuse Medical voluntarily deregisters common stock, suspends SEC reporting

Fuse Medical, Inc.

Filed Form 15 to voluntarily deregister common stock and suspend Exchange Act reporting effective Sept 27, 2023.
Board cites cost savings, undervaluation, and low trading volume as reasons for deregistration.
Expects significant annual expense reduction from lower professional fees and compliance costs.
Will continue trading on OTC Pink (FZMD) with annual financial statements and operational updates via website.
Management to focus on long-term growth without short-term stock price distractions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.